骨代谢生化指标临床应用专家共识(2020)

2020-04-01 中国骨科相关专家小组(统称) 中国骨质疏松杂志.2020.4

骨代谢生化指标包括钙磷代谢调节指标、骨形成标志物、骨吸收标志物、激素与细胞因子。骨代谢生化指标分别来源于骨、软骨、软组织、皮肤、肝、肾、小肠、血液及内分泌腺体等,是由成骨细胞或破骨细胞分泌的酶和激素,

中文标题:

骨代谢生化指标临床应用专家共识(2020)

发布日期:

2020-04-01

简要介绍:

骨代谢生化指标包括钙磷代谢调节指标、骨形成标志物、骨吸收标志物、激素与细胞因子。骨代谢生化指标分别来源于骨、软骨、软组织、皮肤、肝、肾、小肠、血液及内分泌腺体等,是由成骨细胞或破骨细胞分泌的酶和激素,以及骨基质的胶原蛋白代谢产物或非胶原蛋白。骨代谢生化指标可及时反映骨转换状态,灵敏度高、特异性强,用于骨质疏松诊断分型、预测骨折风险、抗骨质疏松治疗疗效评价,以及代谢性骨病的鉴别诊断。并且在骨质疏松流行病学、发病机制、骨质疏松药物的研究方面具有重要的临床意义。

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=8726f1c0018891a4, title=骨代谢生化指标临床应用专家共识(2020), enTitle=, guiderFrom=中国骨质疏松杂志.2020.4, authorId=0, author=, summary=骨代谢生化指标包括钙磷代谢调节指标、骨形成标志物、骨吸收标志物、激素与细胞因子。骨代谢生化指标分别来源于骨、软骨、软组织、皮肤、肝、肾、小肠、血液及内分泌腺体等,是由成骨细胞或破骨细胞分泌的酶和激素,, cover=https://img.medsci.cn/202049/1586436466348_2020535.jpg, journalId=0, articlesId=null, associationId=717, associationName=中国骨科相关专家小组(统称), associationIntro=本制定者非特指某个专家小组,为统称。, copyright=0, guiderPublishedTime=Wed Apr 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p style="color: #373737;">骨代谢生化指标包括钙磷代谢调节指标、骨形成标志物、骨吸收标志物、激素与细胞因子。骨代谢生化指标分别来源于骨、软骨、软组织、皮肤、肝、肾、小肠、血液及内分泌腺体等,是由成骨细胞或破骨细胞分泌的酶和激素,以及骨基质的胶原蛋白代谢产物或非胶原蛋白。骨代谢生化指标可及时反映骨转换状态,灵敏度高、特异性强,用于骨质疏松诊断分型、预测骨折风险、抗骨质疏松治疗疗效评价,以及代谢性骨病的鉴别诊断。并且在骨质疏松流行病学、发病机制、骨质疏松药物的研究方面具有重要的临床意义。</p>, tagList=[TagDto(tagId=97226, tagName=骨代谢生化指标)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4557, guiderKeyword=骨代谢, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3439, appHits=236, showAppHits=11, pcHits=1369, showPcHits=3282, likes=3, shares=14, comments=11, approvalStatus=1, publishedTime=Thu Apr 09 20:59:28 CST 2020, publishedTimeString=2020-04-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Apr 09 20:47:59 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 07:03:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=997632, encodeId=318499e63265, content=非常有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b5c1683030, createdName=1de3c848m58(暂无匿称), createdTime=Thu Jul 08 17:54:37 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973268, encodeId=43719e32688b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Sun Jun 13 14:03:02 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960041, encodeId=5cd096004193, content=求原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/18a954c0045f48919468e2d64ab1d12b/bbfbda28c17e416b99b2ad9c3768fc90.jpg, createdBy=08045280626, createdName=金龟子, createdTime=Sat Apr 24 16:10:38 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902787, encodeId=d379902e8726, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82821749088, createdName=ms6736557359561843, createdTime=Fri Nov 27 12:51:25 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884404, encodeId=2d3a884404d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3c5410793, createdName=蓝莓, createdTime=Fri Sep 11 01:30:09 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2021-07-08 1de3c848m58(暂无匿称)

    非常有意义

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=997632, encodeId=318499e63265, content=非常有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b5c1683030, createdName=1de3c848m58(暂无匿称), createdTime=Thu Jul 08 17:54:37 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973268, encodeId=43719e32688b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Sun Jun 13 14:03:02 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960041, encodeId=5cd096004193, content=求原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/18a954c0045f48919468e2d64ab1d12b/bbfbda28c17e416b99b2ad9c3768fc90.jpg, createdBy=08045280626, createdName=金龟子, createdTime=Sat Apr 24 16:10:38 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902787, encodeId=d379902e8726, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82821749088, createdName=ms6736557359561843, createdTime=Fri Nov 27 12:51:25 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884404, encodeId=2d3a884404d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3c5410793, createdName=蓝莓, createdTime=Fri Sep 11 01:30:09 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2021-06-13 12192b1am98暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=997632, encodeId=318499e63265, content=非常有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b5c1683030, createdName=1de3c848m58(暂无匿称), createdTime=Thu Jul 08 17:54:37 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973268, encodeId=43719e32688b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Sun Jun 13 14:03:02 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960041, encodeId=5cd096004193, content=求原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/18a954c0045f48919468e2d64ab1d12b/bbfbda28c17e416b99b2ad9c3768fc90.jpg, createdBy=08045280626, createdName=金龟子, createdTime=Sat Apr 24 16:10:38 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902787, encodeId=d379902e8726, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82821749088, createdName=ms6736557359561843, createdTime=Fri Nov 27 12:51:25 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884404, encodeId=2d3a884404d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3c5410793, createdName=蓝莓, createdTime=Fri Sep 11 01:30:09 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2021-04-24 金龟子

    求原文

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=997632, encodeId=318499e63265, content=非常有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b5c1683030, createdName=1de3c848m58(暂无匿称), createdTime=Thu Jul 08 17:54:37 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973268, encodeId=43719e32688b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Sun Jun 13 14:03:02 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960041, encodeId=5cd096004193, content=求原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/18a954c0045f48919468e2d64ab1d12b/bbfbda28c17e416b99b2ad9c3768fc90.jpg, createdBy=08045280626, createdName=金龟子, createdTime=Sat Apr 24 16:10:38 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902787, encodeId=d379902e8726, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82821749088, createdName=ms6736557359561843, createdTime=Fri Nov 27 12:51:25 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884404, encodeId=2d3a884404d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3c5410793, createdName=蓝莓, createdTime=Fri Sep 11 01:30:09 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2020-11-27 ms6736557359561843

    好东西

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=997632, encodeId=318499e63265, content=非常有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b5c1683030, createdName=1de3c848m58(暂无匿称), createdTime=Thu Jul 08 17:54:37 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973268, encodeId=43719e32688b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Sun Jun 13 14:03:02 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960041, encodeId=5cd096004193, content=求原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/18a954c0045f48919468e2d64ab1d12b/bbfbda28c17e416b99b2ad9c3768fc90.jpg, createdBy=08045280626, createdName=金龟子, createdTime=Sat Apr 24 16:10:38 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902787, encodeId=d379902e8726, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82821749088, createdName=ms6736557359561843, createdTime=Fri Nov 27 12:51:25 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884404, encodeId=2d3a884404d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3c5410793, createdName=蓝莓, createdTime=Fri Sep 11 01:30:09 CST 2020, time=2020-09-11, status=1, ipAttribution=)]
    2020-09-11 蓝莓

    学习

    0

拓展阅读

2010RA临床实践指南:慢性肾脏病矿物质和骨代谢紊乱指南

英国肾脏病协会(RA,The Renal Association) · 2010-12-06

骨代谢标志物在骨质疏松诊疗中的应用指南(2012年版)

日本骨质疏松症学会(JOS,Japan Osteoporosis Society) · 2012-10-10

2014 中国老年学学会骨质疏松委员会骨代谢生化指标临床应用专家共识

中国老年学学会骨质疏松委员会(OCCGS,Osteoporosis Committee of China Gerontological Society) · 2014-11-20

2015 骨代谢生化标志物临床应用指南

中华医学会骨质疏松和骨矿盐疾病分会(Chinese Medical Association) · 2015-12-04